| Website | denator.com |
| Category | BioTech |
| Phone | 46-(0)31-412-841 |
| Employees |
| TOTAL | $186M |
| VENTURE FUNDING TOTAL | $186M |
| Series A, 4/06 T-bolaget | $664k |
| Series B, 2/07 T-bolaget Servisen Investment Management | $2.16M |
| Series D, 1/11 T-bolaget Wikow Ventures SGP Group Servisen Holding | $1.7M |
| Series F, 4/12 Almi Invest | kr25.5M |
Utilizing a patent-pending technology to instantly and completely stop the degradation process and maintain sample stability thereafter, Denator aims to become the leading supplier of instruments and consumables that enable scientists to stabilize biological tissues and fluids at the moment of sampling thereby enhancing the quality and value of subsequent analytical results.
